#United States #San Diego #Clinical Trials #DermTech #Smart Sticker

DermTech 2.0 Expands Its Clinical Trial Services

In a notable advancement in precision dermatology, DermTech 2.0, also known as DermTech LLC, has announced the expansion of its DermTech Stratum service offering. This expansion introduces comprehensive clinical trial and protocol support services, designed to enhance efficiency for its clients in the biopharma and research sectors.

What is DermTech Stratum?

DermTech Stratum utilizes DermTech's innovative Smart Sticker®, a non-invasive skin sample collection platform that allows researchers to collect genomic and other analyses from lesional and non-lesional skin samples. This technology simplifies the process for researchers, eliminating the need for surgical biopsies, which can be difficult to obtain in clinical studies.

New Clinical Trial Support Services

The new services encompass site access as well as dedicated management support for clinical trials. The team behind DermTech Stratum boasts decades of experience in clinical trial management, ensuring that the expansion not only streamlines processes but also adds value to the customer experience. According to Dr. Burkhard Jansen, President of DermTech 2.0, the addition of these services represents an exciting step forward for the company. He emphasizes that they believe this move will improve overall efficiency and service quality for their partners.

What the Smart Sticker® Provides

The Smart Sticker® is designed to collect approximately 1.5mg of stratum corneum tissue from the skin, which is crucial for genomic studies. One of its standout features is its ability to preserve biological material for extended periods. It can maintain the genomic and proteomic content at room temperature for up to 15 days, and for more than a year when stored at a very low temperature of -80°C.

Moreover, DermTech Stratum has access to a curated clinical tissue bank, which holds over 10,000 non-invasively obtained skin samples from a variety of immunological and inflammatory skin conditions. This resource adds significant value for research teams looking for relevant samples to support their studies.

Supporting Various Applications

The DermTech Stratum platform is particularly suited for indications where the skin is the target or a surrogate for drug development and discovery. It is currently being utilized in research related to cancers and inflammatory diseases, showcasing its versatility and application in serious health issues. Over 30 pharmaceutical companies and research partners have already trusted DermTech Stratum services, affirming its reliability and importance in clinical settings.

Upcoming Opportunities

For those interested in learning more, DermTech will be showcasing its expanded Stratum services at the upcoming American Academy of Dermatology meeting, taking place in Denver, Colorado. This represents an excellent opportunity for industry professionals to connect with the DermTech team and explore how these new services can enhance their clinical trial processes.

Conclusion

With the expansion of its DermTech Stratum services, DermTech 2.0 is positioning itself at the forefront of precision dermatology. The incorporation of clinical trial support capabilities complements its innovative skin sample collection methods, potentially transforming the landscape of clinical research in dermatology and beyond.

For further details about the services offered by DermTech Stratum, including client inquiries or collaborative opportunities, you can visit their website at www.dermtechstratum.com.